VolitionRX Limited (VNRX) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello everyone and thank you for standing by. Welcome to VolitionRX Limited's second quarter 2026 earnings conference call. During today's presentation, all parties will be in a listen only mode. Following the presentation, the conference call will be open for questions. If you have a question, please press the star key followed by the number one on your touch tone phone. If you would like to withdraw your question, please press the star key followed by the number two. If you're using speaker equipment, please flip the handset before making your selections. This conference call is being recorded today, August 14th, 2026. I'd now like to turn the conference call over to Louise Batchelor, Group Chief Marketing and Communications Officer. Please go ahead. Welcome everyone to today's earnings conference call for VolitionRX Limited. Before we begin, I'd like to remind everyone that some of the information discussed on this conference call will include forward-looking statements covered under the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions. Actual future results may vary significantly based on a number of factors that may cause the actual results or events to be materially different from future results, performance or achievements expressed or implied by these statements. We have identified various risk factors associated with our operations in our most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and other filings with the Securities and Exchange Comm...